Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.

Autor: Nebgen DR; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kotsopoulos J; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada., de Hullu JA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands., Crosbie EJ; Division of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK., Paramanandam VS; Department of Obstetrics and Gynaecology, The Royal Women's Hospital, The University of Melbourne, Melbourne, Victoria, Australia., Brood-van Zanten MMA; Department of Gynecology, The Netherlands Cancer Institute, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Norquist BM; Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA., Guise T; Department of Endocrine Neoplasia and Hormone Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rozenberg S; Department of Obstetrics and Gynaecology, Universite Libre de Bruxelles, Brussels, Belgium., Kurian AW; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Pederson HJ; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Yuksel N; Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada., Michaelson-Cohen R; Department of Gynaecology and Medical Genetics Institute, Hebrew University Faculty of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel., Bober SL; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., da Silva Filho AL; Departamento de Ginecologia e Obstetricia da UFMG, Federal University of Minas Gerais, Belo Horizonte, Brazil., Johansen N; Department of Gynaecology and Obstetrics, Sørlandet Hospital HF Arendal, Arendal, Norway., Guidozzi F; Deparment of Obstetrics and Gynaecology, University of Witwatersrand, Johanesburg, South Africa., Evans DG; University of Manchester, Prevent Breast Cancer Centre, Manchester, UK., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Kingsberg SA; University Hospitals Cleveland Medical Center, Case Western University School of Medicine, Cleveland, Ohio, USA., Powell CB; Kaiser Permanente Northern California, Hereditary Cancer Program, San Francisco, California, USA., Grandi G; Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy., Marchetti C; Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Catholic University Sacred Heart, Rome, Italy., Jacobson M; Women's College Hospital and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Brennan DJ; UCD Gynaecological Oncology Group, UCD School of Medicine, Mater University Hospital, Dublin, Ireland., Hickey M; Department of Obstetrics and Gynaecology, Research Precinct, Level 7, The Royal Women's Hospital, University of Melbourne, Parkville, Victoria, Australia.
Jazyk: angličtina
Zdroj: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2023 Nov; Vol. 130 (12), pp. 1437-1450. Date of Electronic Publication: 2023 May 02.
DOI: 10.1111/1471-0528.17511
Abstrakt: Women at high inherited risk of ovarian cancer are offered risk-reducing salpingo-oophorectomy (RRSO) from age 35 to 45 years. Although potentially life-saving, RRSO may induce symptoms that negatively affect quality of life and impair long-term health. Clinical care following RRSO is often suboptimal. This scoping review describes how RRSO affects short- and long-term health and provides evidence-based international consensus recommendations for care from preoperative counselling to long-term disease prevention. This includes the efficacy and safety of hormonal and non-hormonal treatments for vasomotor symptoms, sleep disturbance and sexual dysfunction and effective approaches to prevent bone and cardiovascular disease.
(© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: